Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adeno-associated viral vectors: background and technical aspects

H W Snoeck1, W Tao, M E Klotman

  • 1Department of Medicine, Mount Sinai School of Medicine, New York, N.Y. 10029, USA.

Experimental Nephrology
|January 23, 1998
PubMed
Summary

Adeno-associated virus vectors show promise for gene therapy, particularly for kidney applications. Their ability to safely deliver genes to non-dividing cells with long-term expression makes them a strong candidate for clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review: European Union legislation and regulatory framework for edible insect production - Safety issues.

Animal : an international journal of animal bioscience·2025
Same author

[Efficacy of Rezūm water vapor thermal therapy system in the treatment of benign prostatic hyperplasia in high-risk elderly patients].

Zhonghua yi xue za zhi·2025
Same author

[Soy isoflavones alleviates calcium overload in rats with cerebral ischemia-reperfusion by inhibiting the Wnt/Ca<sup>2+</sup> signaling pathway].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

[Exogenous leptin improves cerebral ischemia-reperfusion-induced glutamate excitotoxic injury in mice by up-regulating GLT-1 and GLAST expression in astrocytes].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

[Investigation on prevalence of <i>Schistosoma japonicum</i> infections in wild mice in Shitai County, Anhui Province, 2018].

Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control·2023
Same author

The Safety and Efficacy of Flow Diversion versus Conventional Endovascular Treatment for Intracranial Aneurysms: A Meta-analysis of Real-world Cohort Studies from the Past 10 Years.

AJNR. American journal of neuroradiology·2022

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy faces challenges in clinical application, often specific to disease and target organ.
  • Effective gene delivery to the kidney requires safe vectors that transduce non-dividing cells and ensure long-term expression.

Purpose of the Study:

  • To evaluate adeno-associated virus (AAV) vectors as a potential solution for gene delivery challenges in kidney gene therapy.
  • To highlight the advantages of AAV vectors for clinical gene therapy applications.

Main Methods:

  • Review of adeno-associated virus (AAV) properties, including its wild-type characteristics and recombinant vector potential.
  • Analysis of AAV's ability to integrate into the host genome and transduce non-dividing cells.
  • Assessment of AAV's immunogenicity and potential for long-term gene expression.

Related Experiment Videos

Main Results:

  • Adeno-associated virus (AAV) vectors are nonpathogenic and can integrate site-specifically.
  • Recombinant AAV vectors efficiently integrate into the host genome, transduce non-dividing cells, and do not elicit an immune response.
  • AAV vectors offer potential for safe, long-term gene expression in target organs like the kidney.

Conclusions:

  • Adeno-associated virus (AAV) vectors possess desirable characteristics for gene therapy, including safety, efficiency in transducing non-dividing cells, and potential for long-term expression.
  • Further research into AAV life cycle and high-titer production will advance its clinical application.
  • AAV vectors represent a promising platform for overcoming current gene therapy obstacles, especially for kidney-targeted treatments.